Catarina Eloy | Health Professions | Women Researcher Award

Posted on by Shen Awards

Prof. Catarina Eloy | Health Professions | Women Researcher Award

IPATIMUP, Portugal

Dr. Catarina Eloy is a distinguished pathologist and researcher specializing in digital pathology and oncologic diagnostics. She has significantly contributed to the integration of artificial intelligence (AI) in pathology, enhancing diagnostic accuracy and efficiency. As a key figure in the HEROHE Challenge, Dr. Eloy collaborated with international experts to develop AI models for predicting HER2 status in breast cancer using hematoxylin–eosin-stained whole-slide images. Her work emphasizes the importance of digital tools in modern pathology, aiming to bridge the gap between traditional histopathology and emerging computational methods. Dr. Eloy’s research has been pivotal in advancing the field, particularly in the context of the COVID-19 pandemic, where digital pathology played a crucial role in maintaining diagnostic services. Her contributions extend beyond research, as she actively participates in international collaborations and initiatives to promote the adoption of digital pathology worldwide. Dr. Eloy’s dedication to innovation and excellence has established her as a leading authority in the field, influencing both clinical practice and research methodologies in pathology.

Professional Profile

Education

Dr. Catarina Eloy’s educational background is rooted in medicine and pathology, providing a strong foundation for her career in digital pathology and oncologic diagnostics. She obtained her medical degree from a reputable institution, followed by specialized training in pathology. Her academic pursuits included advanced studies in digital pathology, where she focused on integrating computational tools with traditional histopathological techniques. Dr. Eloy’s commitment to education is evident through her involvement in various training programs and workshops aimed at disseminating knowledge in digital pathology. She has also contributed to academic literature, authoring several publications that serve as educational resources for both students and professionals in the field. Her educational journey reflects a continuous pursuit of knowledge and a dedication to advancing the field of pathology through both learning and teaching.

Professional Experience

Dr. Catarina Eloy has amassed extensive professional experience in pathology, with a particular focus on digital pathology and oncologic diagnostics. She has held key positions in various institutions, where she has been instrumental in implementing digital pathology workflows and integrating AI tools into diagnostic processes. Her professional journey includes collaborative projects like the HEROHE Challenge, where she worked alongside international experts to develop AI models for breast cancer diagnostics. Dr. Eloy has also contributed to global initiatives aimed at promoting digital pathology, especially during the COVID-19 pandemic, highlighting the importance of digital tools in maintaining diagnostic services. Her leadership and expertise have significantly influenced the adoption of digital pathology practices, enhancing diagnostic accuracy and efficiency across various healthcare settings.

Research Interests

Dr. Catarina Eloy’s research interests are centered around the integration of digital tools in pathology, with a particular emphasis on artificial intelligence and its applications in oncologic diagnostics. She is deeply involved in exploring how AI can enhance the accuracy and efficiency of pathological diagnoses, especially in breast cancer. Her work in the HEROHE Challenge exemplifies her commitment to developing AI models that can predict HER2 status from histopathological images, thereby contributing to personalized medicine. Additionally, Dr. Eloy is interested in the broader implications of digital pathology, including its role in global health and its potential to revolutionize diagnostic practices. Her research aims to bridge the gap between traditional pathology and emerging digital technologies, fostering innovation in diagnostic methodologies.

Research Skills

Dr. Catarina Eloy possesses a robust set of research skills that underpin her contributions to digital pathology and oncologic diagnostics. Her expertise includes proficiency in histopathological analysis, digital imaging, and the application of AI algorithms in diagnostic processes. She is adept at designing and conducting research studies that explore the integration of digital tools in pathology, as evidenced by her involvement in the HEROHE Challenge. Dr. Eloy is also skilled in collaborative research, working with multidisciplinary teams to advance the field of digital pathology. Her analytical capabilities and methodological rigor have been instrumental in producing high-impact research that informs both clinical practice and future studies.

Awards and Honors

Dr. Catarina Eloy’s contributions to pathology have been recognized through various awards and honors. Her work in digital pathology and AI integration has garnered international attention, leading to accolades that highlight her influence in the field. While specific awards are not detailed in the available sources, her leadership roles in significant projects like the HEROHE Challenge and her involvement in global initiatives during the COVID-19 pandemic underscore her esteemed position in the pathology community. These recognitions reflect her dedication to advancing pathology through innovation and collaboration.

Conclusion

Dr. Catarina Eloy’s career embodies a commitment to innovation, collaboration, and excellence in pathology. Her pioneering work in digital pathology and the integration of AI into diagnostic processes has significantly advanced the field, offering new avenues for accurate and efficient patient care. Through initiatives like the HEROHE Challenge, she has demonstrated the potential of interdisciplinary collaboration in developing cutting-edge diagnostic tools. Dr. Eloy’s contributions during the COVID-19 pandemic further highlight the critical role of digital pathology in maintaining healthcare services amidst global challenges. Her dedication to research, education, and professional development continues to inspire advancements in pathology, solidifying her status as a leading figure in the field.

Publications Top Notes

  • Title: Classification of breast cancer histology images using convolutional neural networks
    Authors: T. Araújo, G. Aresta, E. Castro, J. Rouco, P. Aguiar, C. Eloy, A. Polónia, …
    Journal: PLoS ONE, 12(6): e0177544
    Year: 2017
    Citations: 1162

  • Title: Bach: Grand challenge on breast cancer histology images
    Authors: G. Aresta, T. Araújo, S. Kwok, S. S. Chennamsetty, M. Safwan, V. Alex, …
    Journal: Medical Image Analysis, 56: 122–139
    Year: 2019
    Citations: 742

  • Title: TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
    Authors: M. Melo, A. G. da Rocha, J. Vinagre, R. Batista, J. Peixoto, C. Tavares, …
    Journal: The Journal of Clinical Endocrinology & Metabolism, 99(5): E754–E765
    Year: 2014
    Citations: 641

  • Title: Follicular thyroid carcinoma
    Authors: M. Sobrinho-Simões, C. Eloy, J. Magalhães, C. Lobo, T. Amaro
    Journal: Modern Pathology, 24: S10–S18
    Year: 2011
    Citations: 223

  • Title: Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas
    Authors: P. Soares, J. Lima, A. Preto, P. Castro, J. Vinagre, R. Celestino, J. P. Couto, …
    Journal: Current Genomics, 12(8): 609–617
    Year: 2011
    Citations: 127

  • Title: Best practice recommendations for the implementation of a digital pathology workflow in the anatomic pathology laboratory by the European Society of Digital and Integrative Pathology
    Authors: F. Fraggetta, V. L’imperio, D. Ameisen, R. Carvalho, S. Leh, T. R. Kiehl, …
    Journal: Diagnostics, 11(11): 2167
    Year: 2021
    Citations: 92

  • Title: NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features
    Authors: C. Tavares, M. J. Coelho, C. Eloy, M. Melo, A. G. da Rocha, A. Pestana, …
    Journal: Endocrine Connections, 7(1): 78–90
    Year: 2018
    Citations: 85

  • Title: Automatic classification of tissue malignancy for breast carcinoma diagnosis
    Authors: I. Fondón, A. Sarmiento, A. I. García, M. Silvestre, C. Eloy, A. Polónia, P. Aguiar
    Journal: Computers in Biology and Medicine, 96: 41–51
    Year: 2018
    Citations: 83

  • Title: Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade
    Authors: M. A. Berbís, D. S. McClintock, A. Bychkov, J. Van der Laak, L. Pantanowitz, …
    Journal: EBioMedicine, 88
    Year: 2023
    Citations: 78

  • Title: Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway
    Authors: J. M. Cameselle-Teijeiro, D. Peteiro-González, J. Caneiro-Gómez, …
    Journal: Modern Pathology, 31(8): 1168–1179
    Year: 2018
    Citations: 72

Recinda Sherman | Health Professions | Best Researcher Award

Posted on by Shen Awards

Dr. Recinda Sherman | Health Professions | Best Researcher Award

North American Association of Central Cancer Registries (NAACCR), United States

Dr. Recinda L. Sherman is a distinguished public health professional specializing in cancer surveillance and epidemiology. She currently serves as the Program Manager of Data Use and Research at the North American Association of Central Cancer Registries (NAACCR), where she oversees the development and dissemination of cancer data products, including the CiNA (Cancer in North America) data series . With a PhD and MPH, Dr. Sherman has a robust academic background that underpins her extensive experience in managing large-scale cancer data and contributing to public health research. Her work is pivotal in informing cancer control strategies and health policy decisions across North America.

Professional Profile

Education

Dr. Sherman holds a Doctor of Philosophy (PhD) and a Master of Public Health (MPH), reflecting her deep academic engagement in public health and epidemiology. Her educational journey has equipped her with the expertise necessary for high-level research and data analysis in cancer surveillance. Additionally, she is a Certified Tumor Registrar (CTR), a credential that underscores her proficiency in cancer data collection and registry operations . Her academic and professional qualifications have been instrumental in her contributions to cancer epidemiology and public health initiatives.

Professional Experience

In her role at NAACCR, Dr. Sherman manages data use and research programs, focusing on the quality and utility of cancer registry data. She has been involved in various projects aimed at improving cancer data collection and analysis, including the development of best practices for geocoding in cancer registries . Her professional experience also includes serving as an adjunct professor at Claremont Graduate University, where she contributes to the academic development of future public health professionals . Dr. Sherman’s career reflects a commitment to enhancing cancer surveillance and fostering research that informs public health policy.

Research Interests

Dr. Sherman’s research interests encompass cancer epidemiology, spatial analysis, and health disparities. She has authored numerous publications that explore patterns in cancer incidence and mortality, with a particular focus on geographic and demographic disparities . Her work often involves the application of geospatial techniques to understand the distribution of cancer cases and to identify areas in need of targeted public health interventions. Dr. Sherman’s research contributes to a deeper understanding of the factors influencing cancer outcomes and supports the development of strategies to address inequities in cancer care.

Research Skills

Dr. Sherman possesses a comprehensive skill set in epidemiological research, including expertise in cancer surveillance, spatial epidemiology, and public health data analysis. Her proficiency in geocoding and GIS applications enables her to conduct detailed spatial analyses of cancer data, which are crucial for identifying trends and informing public health strategies . Additionally, her experience in managing large datasets and her knowledge of cancer registry operations position her as a leader in the field of cancer epidemiology. Dr. Sherman’s research skills are integral to her contributions to public health research and policy development.

Awards and Honors

Dr. Sherman’s contributions to cancer epidemiology and public health have been recognized through various awards and honors. While specific accolades are not detailed in the available sources, her leadership role at NAACCR and her involvement in significant research projects underscore her standing in the field. Her work has been instrumental in advancing cancer surveillance practices and in promoting the use of high-quality data for public health decision-making. Dr. Sherman’s professional achievements reflect her dedication to improving cancer outcomes and her impact on public health research.​

Conclusion

Dr. Recinda L. Sherman is a prominent figure in cancer epidemiology, with a career dedicated to enhancing cancer surveillance and informing public health policy. Her academic background, professional experience, and research expertise have positioned her as a leader in the field. Through her work at NAACCR and her academic contributions, Dr. Sherman continues to influence the collection and analysis of cancer data, supporting efforts to reduce cancer disparities and improve health outcomes. Her commitment to public health and her contributions to cancer research exemplify the critical role of epidemiologists in advancing healthcare.

Publications Top Notes

  1. Cancer incidence among Marines and Navy personnel and civilian workers exposed to industrial solvents in drinking water at US Marine Corps Base Camp Lejeune: A cohort study
    Authors: Frank J. Bove, April A. Greek, Ruth Gatiba, Gene T. Shin, Aaron Bernstein
    Journal: Environmental Health Perspectives
    Year: 2024
    Citations: 1

  2. Annual Report to the Nation on the Status of Cancer, Part 2: Early assessment of the COVID-19 pandemic’s impact on cancer diagnosis
    Authors: Serban Negoita, Huann Sheng Chen, Pamela V. Sanchez, Ahmedin M. Jemal, Kathleen A. Cronin
    Journal: Cancer
    Year: 2024
    Citations: 24

  3. Annual Report to the Nation on the Status of Cancer, Part 1: National cancer statistics
    Authors: Kathleen A. Cronin, Susan M. Scott, Albert U. Firth, William G. Cance, Ahmedin M. Jemal
    Journal: Cancer
    Year: 2022
    Citations: 308

  4. Annual Report to the Nation on the Status of Cancer, Part 2: Patient economic burden associated with cancer care
    Authors: Robin Yabroff, Ângela B. Mariotto, Florence K.L. Tangka, Ahmedin M. Jemal, Elizabeth M. Ward
    Journal: Journal of the National Cancer Institute
    Year: 2021
    Citations: 126

  5. Annual Report to the Nation on the Status of Cancer, Part 1: National cancer statistics
    Authors: Farhad Islami, Elizabeth M. Ward, Hyuna Sung, Robin Yabroff, Vicki B. Benard
    Journal: Journal of the National Cancer Institute
    Year: 2021
    Citations: 354

​

Ariel Wolf | Social Determinants | Best Researcher Award

Posted on by Shen Awards

Dr. Ariel Wolf | Social Determinants | Best Researcher Award

Neurologo at University of Colorado Surgery Department, United States

Dr. Ariel Wolf is a highly accomplished medical professional currently engaged in a General Surgery Residency at the University of Colorado. He holds a Doctor of Medicine from FIU Herbert Wertheim College of Medicine and has a robust background in biological sciences, with a Bachelor’s degree from the University of Chicago. Dr. Wolf’s research contributions span trauma surgery, colorectal surgery, and cardiovascular treatments, reflected in his numerous publications and presentations at prestigious conferences such as AAST and SAGES. His work is particularly notable for its focus on improving surgical outcomes and patient care, evidenced by studies on blunt cerebrovascular injuries, spinal anesthesia, and emergency general surgery. Additionally, Dr. Wolf has co-authored book chapters on cardiac therapies and plastic surgery techniques, further solidifying his expertise. His collaborative research efforts and dedication to advancing medical knowledge make him a standout candidate in the field of surgery.

Profile

Education

Dr. Reema Qayoom’s educational journey reflects a strong foundation in medical sciences and a commitment to excellence. She completed her Bachelor of Medicine, Bachelor of Surgery (MBBS) from Liaquat University of Medical and Health Sciences (LUMHS) in Jamshoro from 2007 to 2012. Prior to this, she achieved her Intermediate education from the Board of Intermediate and Secondary Education, Karachi, between 2005 and 2007, and her Matriculation from the same board, completing it in 2005. Her educational background is complemented by numerous certifications, including MRCP UK and FCPS qualifications, enhancing her expertise in cardiology. Dr. Qayoom’s rigorous academic training has provided her with a solid clinical and theoretical foundation, equipping her to excel in her professional endeavors and contribute significantly to the field of cardiology.

Professional Experience

Dr. Ariel Wolf is a distinguished medical professional currently pursuing a General Surgery Residency at the University of Colorado, Aurora. Previously, he completed a General Surgery Residency at Florida Atlantic University, Boca Raton, from 2020 to 2024. Dr. Wolf earned his Doctor of Medicine degree from FIU Herbert Wertheim College of Medicine, Miami, in 2020, following a Bachelor of Arts in Biological Sciences from the University of Chicago in 2013. Dr. Wolf’s experience spans various aspects of surgery, with notable contributions to research and clinical practice. He has actively participated in numerous presentations and publications, showcasing his expertise in trauma, colorectal surgery, and emergency general surgery. His collaborative efforts with renowned researchers have led to significant advancements in surgical procedures and patient outcomes. Dr. Wolf’s dedication to excellence and continuous learning underscores his commitment to the field of surgery and his aspiration to impact healthcare positively.

Research Interests

Dr. Ariel Wolf’s research interests span a broad spectrum of topics within the realm of surgery and medical science. His primary focus lies in trauma and emergency surgery, with a keen interest in improving patient outcomes through innovative surgical techniques and procedures. Dr. Wolf is particularly dedicated to exploring the efficacy of endovascular treatments and the optimization of surgical protocols to reduce complications, such as surgical site infections and pulmonary morbidity. He is also deeply involved in studying the impact of spinal anesthesia on colorectal surgery outcomes and the role of ureteral stenting in elective colorectal surgeries. Additionally, Dr. Wolf’s research extends to the management of thoracic trauma and the socioeconomic factors influencing healthcare access and outcomes. His work is characterized by a commitment to evidence-based practice and a multidisciplinary approach, often collaborating with experts in various fields to enhance the quality and effectiveness of surgical care.

Research Skills

Dr. Ariel Wolf possesses a robust skill set tailored to research in the medical field, particularly within the realms of surgery and trauma care. His expertise encompasses comprehensive data analysis, rigorous experimental design, and meticulous manuscript preparation, demonstrated through his extensive publication record in high-impact journals. Proficient in various research methodologies, Dr. Wolf excels in retrospective cohort studies, prospective observational studies, and clinical trials. His collaborative approach is evident in his numerous co-authored papers and multidisciplinary projects, which span diverse topics such as colorectal surgery outcomes, thoracic trauma management, and stem cell therapy for cardiac regeneration. Dr. Wolf’s ability to integrate advanced statistical techniques and cutting-edge technology into his research ensures the reliability and relevance of his findings. Additionally, his experience in presenting at prestigious conferences underscores his capability to communicate complex scientific concepts effectively to both academic and clinical audiences.

Awards and Recognition

Dr. Wolf’s excellence in research has been recognized through various awards and honors. His presentations at leading surgical conferences and his successful publication record are testaments to his contributions to the field. These accolades not only highlight his individual achievements but also underscore the impact of his research on the medical community. Recognition from peers and professional organizations affirms the significance of his work and its relevance to advancing surgical practices and patient care.

Conclusion

Dr. Ariel Wolf, M.D., is a highly suitable candidate for the Best Researcher Award due to his extensive contributions to medical research, particularly in the field of surgery. His work has a broad geographic impact, is characterized by strong collaborative efforts, and is deeply rooted in practical, applied research. His numerous publications, commitment to addressing environmental health issues, and contributions to the understanding of parasitology and infectious diseases further bolster his candidacy. Dr. Wolf’s research not only advances scientific knowledge but also has a tangible impact on clinical practices and patient outcomes, making him a deserving recipient of this prestigious award.

Publications Top Notes

  1. Biogas Production Potential of Mixed Banana and Pineapple Waste as Assessed by Long-Term Laboratory-Scale Anaerobic Digestion
    • Authors: Rabinovich, V.A., Linnenberg, C., Theilen, U., Weigand, H.
    • Year: 2024
  2. Fresh and Hardened Properties of Low-Clinker Cementitious Systems with Low-Co2 Footprint Produced with Carbonated Fine Recycled Aggregates
    • Authors: Latifi, M., Pede, T., Dengler, P., Weigand, H., Kern, R.
    • Year: 2024
  3. Household-scale treatment units for reductive removal of hexavalent chromium from groundwater
    • Authors: Bandyopadhyay, T., Bhojwani, V., Weigand, H., Sharma, A., Singh, A.
    • Year: 2023
    • Citations: 1
  4. Post-measurement compressed calibration for ICP-MS-based metal quantification in mine residues bioleaching
    • Authors: Rito, B., Almeida, D., Coimbra, C., Weigand, H., Morais, P.V.
    • Year: 2022
    • Citations: 1
  5. Phosphorus recovery by re-dissolution from activated sludge – effects of carbon source and supplementation level revisited
    • Authors: Anders, A., Weigand, H., Platen, H.
    • Year: 2022
    • Citations: 3
  6. Development and Test of a Rotating Drum Reactor for the Simultaneous Hydration and Carbonation of Dry Biomass Bottom Ash
    • Authors: Schnabel, K., Brück, F., Pohl, S., Weigand, H.
    • Year: 2022
    • Citations: 2
  7. Phosphorus recycling from activated sludge of full-scale wastewater treatment plants by fast inversion of the biological phosphorus elimination mechanism
    • Authors: Anders, A., Weigand, H., Cakir, H., Kornhaas, U., Platen, H.
    • Year: 2021
    • Citations: 7
  8. Technically exploitable mineral carbonation potential of four alkaline waste materials and effects on contaminant mobility
    • Authors: Schnabel, K., Brück, F., Pohl, S., Mansfeldt, T., Weigand, H.
    • Year: 2021
    • Citations: 10
  9. Full-scale accelerated carbonation of waste incinerator bottom ash under continuous-feed conditions
    • Authors: Schnabel, K., Brück, F., Mansfeldt, T., Weigand, H.
    • Year: 2021
    • Citations: 5
  10. Towards optimized drum composting: evaluation of the radial mixing performance of a model substrate on the laboratory scale
    • Authors: Schneider, J., Burg, J.M., Theilen, U., Weigand, H., Brück, F.
    • Year: 2020
    • Citations: 3